(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(thiophen-2-yl)butanoic acid, 97%, 250mg

5-METHOXY-6-NITRO-1H-INDAZOLE, 97.0%, 250mg

N,N-dimetilanilina, >=99%, per sintesi, 2,5 L, confezione in vetro

4,6-Dichloropyrimidine-5-carbonitrile, 95.0%, 10g

5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)-pyridine, 98.0%, 1g

3,4-Difluoro-2-hydroxybenzoic acid, 99.0%, 1g

Ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate, 96+%, 5g

N-(2,4-Dimethoxybenzyl)-1,2,4-thiadiazol-5-amine, 95.0%, 10g

2-Bromo-5-(piperidin-1-yl)pyridine, 97.0%, 250mg

1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole, 95.0%, 25g

Tartrato di potassio e sodio tetraidrato, minimo 99%, pa, ACS, ISO, 1 kg, confezione in plastica.

4-Ethylthiophenylboronic acid, 95.0%, 1g

Potassium trifluoro(4-fluoro-2-methylbenzyl)borate, 98%, 5g